L
Lisa G. Winston
Researcher at University of California, San Francisco
Publications - 54
Citations - 4514
Lisa G. Winston is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Population & Clostridium difficile. The author has an hindex of 22, co-authored 51 publications receiving 3817 citations. Previous affiliations of Lisa G. Winston include Colorado Department of Public Health and Environment & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa,Yi Mu,Wendy Bamberg,Zintars G. Beldavs,Ghinwa Dumyati,John R. Dunn,Monica M. Farley,Stacy Holzbauer,James I. Meek,Erin C Phipps,Lucy E. Wilson,Lisa G. Winston,Jessica Cohen,Brandi Limbago,Scott K. Fridkin,Dale N. Gerding,L. Clifford McDonald +16 more
TL;DR: In this article, the authors used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection.
Journal ArticleDOI
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.
Alice Guh,Yi Mu,Lisa G. Winston,Helen Johnston,Danyel M Olson,Monica M. Farley,Lucy E. Wilson,Stacy Holzbauer,Erin C. Phipps,Ghinwa Dumyati,Zintars G. Beldavs,Marion A. Kainer,Maria Karlsson,Dale N. Gerding,L. Clifford McDonald +14 more
TL;DR: The estimated national burden of C. difficile infection and associated hospitalizations decreased from 2011 through 2017, owing to a decline in health care-associated infections.
Journal ArticleDOI
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Amit S. Chitnis,Stacy Holzbauer,Ruth Belflower,Lisa G. Winston,Wendy Bamberg,Carol Lyons,Monica M. Farley,Monica M. Farley,Ghinwa Dumyati,Lucy E. Wilson,Zintars G. Beldavs,John R. Dunn,L. Hannah Gould,Duncan MacCannell,Dale N. Gerding,Dale N. Gerding,L. Clifford McDonald,Fernanda C. Lessa +17 more
TL;DR: Most patients with community-associated CDI had recent outpatient health care exposure, and up to 36% would not be prevented by reduction of antibiotic use only, and the data support evaluation of additional strategies, including further examination of C difficile transmission in outpatient and household settings and reduction of proton pump inhibitor use.
Journal ArticleDOI
Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysis
TL;DR: It is suggested that adults with mild to moderate community-acquired pneumonia can be safely and effectively treated with an antibiotic regimen of 7 days or less and reduction in patient exposure to antibiotics may limit the increasing rates of antimicrobial drug resistance, decrease cost, and improve patient adherence and tolerance.
Journal ArticleDOI
NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
Isaac See,Yi Mu,Jessica Cohen,Zintars G. Beldavs,Lisa G. Winston,Ghinwa Dumyati,Stacy Holzbauer,John R. Dunn,Monica M. Farley,Carol Lyons,Helen Johnston,Erin C Phipps,Rebecca Perlmutter,Lydia Anderson,Dale N. Gerding,Dale N. Gerding,Fernanda C. Lessa +16 more
TL;DR: Strategies to reduce NAP1 prevalence, such as antibiotic stewardship to reduce fluoroquinolone use, might reduce CDI morbidity.